Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. FDA Announces Change in Status of 12 Peptides SSRP Institute Everything You Need to Know About the FDA Peptide Ban BREAKING: The FDA just reversed their 2023 peptide ban. 12 peptides pulled from the Category 2 restricted list: 1. BPC 157 2. Thymosin beta 4 fragment (TB 500) 3. Epitalon 4. GHK Cu 5. MOTS C 6. Dihexa Research Peptide Protocols: Reconstitution & Storage